Security key
19240Q201
Cogent Biosciences, Inc. - Common Stock (COGT)
CUSIP: 19240Q201
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 90,814,821
- Total 13F value
- $533,992,647
- Share change
- -19,164
- Put/Call ratio
- 114%
- SEC-reported price per share
- $5.88
- Number of holders
- 141
- Value change
- -$45,403,172
- Number of buys
- 87
- Number of sells
- 54
- Shares outstanding
- 170,962,250
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
141
Top holders
10
COGT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Cogent Biosciences, Inc. SEC filings
Cogent Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 19240Q201
Recent filing periods:
Ownership snapshot
Top reported holders of COGT - Cogent Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 3.8%
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 3.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
3.8%
BlackRock Finance, Inc.
3.6%
TCG Crossover Management, LLC
3.3%
Commodore Capital LP
3.3%
Venrock Adviser, LLC
2.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
3.8%
|
$62,557,433
6,416,147 shares
|
— | 30 Sep 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
3.6%
|
$59,934,012
6,147,078 shares
|
— | 30 Sep 2023 |
| TCG Crossover Management, LLC |
13F
Company
|
3.3%
|
$54,902,659
5,631,042 shares
|
— | 30 Sep 2023 |
| Commodore Capital LP |
13F
Company
|
3.3%
|
$54,268,754
5,566,026 shares
|
— | 30 Sep 2023 |
| Venrock Adviser, LLC |
13F
Company
|
2.7%
|
$45,670,628
4,684,167 shares
|
— | 30 Sep 2023 |
| FMR LLC |
13F
Company
|
2.7%
|
$44,555,368
4,569,781 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
141
Shares
90,814,821
Rows available
141
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
134
Q4 2023 holders
141
Holder diff
7
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend